TrialBMC medicine2024

Immunogenicity and safety of RAZI recombinant spike protein vaccine (RCP) as a booster dose after priming with BBIBP-CorV: a parallel two groups, randomized, double blind trial.

Saeed Erfanpoor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.